Literature DB >> 33024272

Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM.

Ting Li1, Nanjing Liu2, Yingying Gao1, Zhen Quan3, Yanni Hao1, Chaowen Yu2, Luo Li1, Mengjuan Yuan3, Lingfang Niu1, Chunli Luo4, Xiaohou Wu5.   

Abstract

BACKGROUND: The role of HOX transcript antisense RNA (HOTAIR) has been proven to be important in tumorigenesis. However, how this molecule promotes metastasis and invasion in PCa is still unclear.
METHODS: The relationship between HOTAIR and hepatocellular adhesion molecule (hepaCAM) in PCa was identified by immunohistochemistry, immunofluorescence, plasmid transfection, quantitative real-time PCR and immunoblotting. The regulatory effects of HOTAIR on hepaCAM and MAPK signalling and their key roles in PCa metastasis were investigated in vitro.
RESULTS: The expression of HOTAIR was inversely correlated with hepaCAM in the blood and tissue of PCa patients. Here, hepaCAM was identified as a novel target gene of HOTAIR and was critical for the invasiveness of PCa. HOTAIR recruited PRC2 to the hepaCAM promoter, resulting in high levels of H3K27me3 and the absence of hepaCAM with an abnormally activated MAPK pathway. Both HOTAIR depletion and EZH2 inhibition could induce hepaCAM re-expression with inhibitory MAPK signalling and decrease the invasive and metastatic capabilities of PCa cells.
CONCLUSIONS: This study demonstrates that HOTAIR promotes invasion and metastasis of PCa by decreasing the inhibitory effect of hepaCAM on MAPK signalling. Therefore, the HOTAIR/hepaCAM/MAPK axis may provide a new avenue towards therapeutic strategies and prognostic indicators for advanced prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33024272      PMCID: PMC7782544          DOI: 10.1038/s41416-020-01091-1

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  36 in total

1.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

2.  Structural and functional analyses of a novel ig-like cell adhesion molecule, hepaCAM, in the human breast carcinoma MCF7 cells.

Authors:  Mei Chung Moh; Chunli Zhang; Chunli Luo; Lay Hoon Lee; Shali Shen
Journal:  J Biol Chem       Date:  2005-05-25       Impact factor: 5.157

3.  PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling.

Authors:  Hao Qin; Xiaoqiu Liu; Fujun Li; Lixia Miao; Tingting Li; Boqun Xu; Xiaofei An; Aaron Muth; Paul R Thompson; Scott A Coonrod; Xuesen Zhang
Journal:  Cancer Lett       Date:  2017-08-24       Impact factor: 8.679

4.  Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer.

Authors:  Xuedong Song; Yin Wang; Hongfei Du; Yanru Fan; Xue Yang; Xiaorong Wang; Xiaohou Wu; Chunli Luo
Journal:  Prostate       Date:  2014-05-08       Impact factor: 4.104

Review 5.  Cellular and molecular processes in ovarian cancer metastasis. A Review in the Theme: Cell and Molecular Processes in Cancer Metastasis.

Authors:  Tsz-Lun Yeung; Cecilia S Leung; Kay-Pong Yip; Chi Lam Au Yeung; Stephen T C Wong; Samuel C Mok
Journal:  Am J Physiol Cell Physiol       Date:  2015-07-29       Impact factor: 4.249

6.  Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells.

Authors:  Warren Fiskus; Yongchao Wang; Arun Sreekumar; Kathleen M Buckley; Huidong Shi; Anand Jillella; Celalettin Ustun; Rekha Rao; Pravina Fernandez; Jianguang Chen; Ramesh Balusu; Sanjay Koul; Peter Atadja; Victor E Marquez; Kapil N Bhalla
Journal:  Blood       Date:  2009-07-28       Impact factor: 22.113

Review 7.  Epigenetic Modifications and Modulators in Prostate Cancer.

Authors:  Alessia Cimadamore; Silvia Gasparrini; Marina Scarpelli; Andrea Doria; Roberta Mazzucchelli; Francesco Massari; Liang Cheng; Antonio Lopez-Beltran; Rodolfo Montironi
Journal:  Crit Rev Oncog       Date:  2017

8.  3-Deazaneplanocin: a new and potent inhibitor of S-adenosylhomocysteine hydrolase and its effects on human promyelocytic leukemia cell line HL-60.

Authors:  R I Glazer; K D Hartman; M C Knode; M M Richard; P K Chiang; C K Tseng; V E Marquez
Journal:  Biochem Biophys Res Commun       Date:  1986-03-13       Impact factor: 3.575

9.  Overexpression of Hepatocyte Cell Adhesion Molecule (hepaCAM) Inhibits the Proliferation, Migration, and Invasion in Colorectal Cancer Cells.

Authors:  Hai-Tao Geng; Rui-Juan Cao; Lei Cheng; Chun-Yuan Liu
Journal:  Oncol Res       Date:  2016-12-15       Impact factor: 5.574

10.  Serum long noncoding RNA HOTAIR as a novel diagnostic and prognostic biomarker in glioblastoma multiforme.

Authors:  Sze Kiat Tan; Chiara Pastori; Clara Penas; Ricardo J Komotar; Michael E Ivan; Claes Wahlestedt; Nagi G Ayad
Journal:  Mol Cancer       Date:  2018-03-20       Impact factor: 27.401

View more
  9 in total

Review 1.  Long non-coding RNA in prostate cancer.

Authors:  Christine An; Ian Wang; Xin Li; Rong Xia; Fangming Deng
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

2.  HOTAIR/miR-1277-5p/ZEB1 axis mediates hypoxia-induced oxaliplatin resistance via regulating epithelial-mesenchymal transition in colorectal cancer.

Authors:  Xingyue Weng; Hao Liu; Jian Ruan; Miaoyan Du; Lingjie Wang; Jiayan Mao; Ying Cai; Xuemei Lu; Wei Chen; Yaqing Huang; Xiao Zhi; Jianzhen Shan
Journal:  Cell Death Discov       Date:  2022-07-07

3.  CTB-193M12.5 Promotes Hepatocellular Carcinoma Progression via Enhancing NSD1-Mediated WNT10B/Wnt/β-Catenin Signaling Activation.

Authors:  Shuhua Zhang; Mi Jiang; Huan Cao; Jun Xiong; Jianqun Xu
Journal:  J Hepatocell Carcinoma       Date:  2022-06-07

Review 4.  From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer.

Authors:  Ekaterina Nevedomskaya; Bernard Haendler
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

Review 5.  Noncoding-RNA-Based Therapeutics with an Emphasis on Prostatic Carcinoma-Progress and Challenges.

Authors:  Victor E Nava; Pin-Yu Perera; Nirbhay Kumar; Maneesh Jain
Journal:  Vaccines (Basel)       Date:  2022-02-11

6.  KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling.

Authors:  Shuhua Zhang; Jianqun Xu; Huan Cao; Mi Jiang; Jun Xiong
Journal:  Front Oncol       Date:  2022-01-20       Impact factor: 6.244

7.  HepaCAM‑PIK3CA axis regulates the reprogramming of glutamine metabolism to inhibit prostate cancer cell proliferation.

Authors:  Zhenting He; Yingying Gao; Ting Li; Chaowen Yu; Liping Ou; Chunli Luo
Journal:  Int J Oncol       Date:  2022-02-22       Impact factor: 5.650

Review 8.  Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.

Authors:  Eva Slabáková; Zuzana Kahounová; Jiřina Procházková; Karel Souček
Journal:  Noncoding RNA       Date:  2021-12-02

9.  Long Noncoding RNA AATBC Promotes the Proliferation and Migration of Prostate Cancer Cell Through miR-1245b-5p/CASK Axis.

Authors:  Wenyuan Zhang; Qionghong Liu; Jun Zhao; Tiejun Wang; Jinshan Wang
Journal:  Cancer Manag Res       Date:  2021-06-28       Impact factor: 3.989

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.